EPO Patent Application: Enforced Mitophagy System
Summary
The European Patent Office has published patent application EP2026030758A2 concerning an enforced mitophagy system designed to reduce mitochondrial abundance in cells and organisms. The application details a method for controlling mitochondrial levels, potentially impacting biotechnology and medical research fields.
What changed
The European Patent Office (EPO) has published patent application EP2026030758A2, titled "AN ENFORCED MITOPHAGY SYSTEM TO REDUCE MITOCHONDRIAL ABUNDANCE FROM CELLS AND ORGANISMS." This publication, dated March 18, 2026, describes a system and method for regulating mitochondrial abundance within cells and organisms. The application is classified under IPC codes C12N 5/0735 and C12N 15/10, indicating its relevance to cell biology and genetic engineering.
This patent application does not impose immediate compliance obligations on regulated entities. However, it represents a development in biotechnology that may influence future research, product development, and intellectual property strategies for companies in the pharmaceutical, biotechnology, and medical device sectors. Compliance officers should note this publication as a potential indicator of emerging technologies in cellular health and therapeutic interventions.
Source document (simplified)
AN ENFORCED MITOPHAGY SYSTEM TO REDUCE MITOCHONDRIAL ABUNDANCE FROM CELLS AND ORGANISMS
Publication EP2026030758A2 Kind: A2 Mar 18, 2026
Inventors
The designation of the inventor has not yet been filed
IPC Classifications
C12N 5/0735 20100101AFI20260208BHEP C12N 15/10 20060101ALI20260208BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Biotech (C12N) publishes new changes.